PILOT CLINICAL STUDY OF GCSF IN COMBINATION WITH DESIPRAMINE FOR AUTOLOGOUS STEM CELL MOBILIZATION IN MULTIPLE MYELOMA

Trial Profile

PILOT CLINICAL STUDY OF GCSF IN COMBINATION WITH DESIPRAMINE FOR AUTOLOGOUS STEM CELL MOBILIZATION IN MULTIPLE MYELOMA

Active, no longer recruiting
Phase of Trial: Phase II

Latest Information Update: 20 Feb 2017

At a glance

  • Drugs Desipramine (Primary) ; Filgrastim (Primary)
  • Indications Multiple myeloma; Stem cell mobilisation
  • Focus Therapeutic Use
  • Most Recent Events

    • 07 Jun 2017 Biomarkers information updated
    • 11 Jan 2016 Planned primary completion date changed from 1 Jan 2016 to 1 March 2015 as reported by ClinicalTrials.gov record.
    • 05 Mar 2015 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top